Embla Medical hfOSSFF 93 Earnings Yield (Joel Greenblatt) % is 5.91% as of Mar. 2026, which is 62% above its 10-year median of 3.65. GuruFocus rates OSSFF with a GF Scoreâ„¢ of 93/100 and a GF Valueâ„¢ of $5.48. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Embla Medical hf ranks better than 77.96% on this metric.
Embla Medical hf's Enterprise Value for the quarter that ended in Mar. 2026 was $2,236.7 Mil.
Embla Medical hf's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $132.0 Mil. Embla Medical hf's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 5.91%.
The historical rank and industry rank for Embla Medical hf's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
OSSFF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.61 Med: 3.65 Max: 6.09
Current: 5.95
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Embla Medical hf was 6.09%. The lowest was 0.61%. And the median was 3.65%.
OSSFF's Earnings Yield (Joel Greenblatt) % is ranked better than 77.96% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs OSSFF: 5.95
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Embla Medical hf's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 15.52%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Embla Medical hf (OTCPK:OSSFF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Embla Medical hf Earnings Yield (Joel Greenblatt) % Related Terms
Embla Medical hf Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, Embla Medical hf's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Earnings Yield (Joel Greenblatt) % falls into.
Embla Medical hf Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Embla Medical hfs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Embla Medical hf's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $132.0 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 5.91% mean?
Embla Medical hf (OSSFF) has a Earnings Yield (Joel Greenblatt) % of 5.91% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Embla Medical hf and its competitors. This is 62% above median its historical median of 3.65. Over the past decade, Embla Medical hf's Earnings Yield (Joel Greenblatt) % has ranged from 0.61 to 6.09. According to the industry distribution chart, Embla Medical hf ranks #188 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 22%.
Is Embla Medical hf's Earnings Yield (Joel Greenblatt) % too high?
Embla Medical hf's current Earnings Yield (Joel Greenblatt) % of 5.91% is 62% above median its 10-year median of 3.65. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 6.09. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.76. Embla Medical hf's value of 5.91% is 677.6% above this industry median. Based on the distribution chart, Embla Medical hf ranks #188 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Embla Medical hf has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Earnings Yield (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #188 out of 853 companies for Earnings Yield (Joel Greenblatt) %. This places Embla Medical hf in the top 22% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 0.76. Embla Medical hf's value of 5.91% is 677.6% above this benchmark. Historically, Embla Medical hf's own Earnings Yield (Joel Greenblatt) % has ranged from 0.61 to 6.09 over the past decade. While the company's 10-year median is 3.65 vs. the industry median of 0.76, Embla Medical hf has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.76, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Earnings Yield (Joel Greenblatt) % of 5.91% is 677.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Earnings Yield (Joel Greenblatt) % is 5.91%, which is 62% above median its own 10-year median of 3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Earnings Yield (Joel Greenblatt) % of 5.91%. The stock's GF Value™ is $5.48, compared to a current price of $4.15 — trading 24.3% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 5.91%, which is 62% above median its 10-year median of 3.65 and 677.6% above the Medical Devices & Instruments industry median of 0.76. Embla Medical hf's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Earnings Yield (Joel Greenblatt) % is 5.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.3% below its estimated GF Value™ of $5.48.
Key valuation signals for OSSFF:
Earnings Yield (Joel Greenblatt) %: 5.91% (62% above median its 10-year median of 3.65)
GF Value™: $5.48 vs. price of $4.15 (24.3% below fair value)
Industry Position: 677.6% above the Medical Devices & Instruments median (#188 of 853)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
93GF Score
Get the complete analysis for OSSFF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
